DUBLIN--(BUSINESS WIRE)--The "Particle
Therapy Market by Type, Products, Services, System, Cancer Type,
Application - Forecast to 2023" report has been added to ResearchAndMarkets.com's
offering.
The global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%
The growth of this market is largely driven by factors such as the
various advantages offered by particle therapy over photon therapy,
growing global prevalence of cancer, increasing adoption of particle
therapy in clinical trials, and the increasing number of particle
therapy centers worldwide.
The cyclotrons segment
is expected to account for the largest market share during the forecast
period
Based on type, the particle therapy
products market is segmented into cyclotrons, synchrotrons, and
synchrocyclotrons. The cyclotrons segment is expected to account for the
largest share of this market in 2018. The development of technologically
advanced systems, advantages offered by cyclotrons over other
accelerators, and the growing adoption of cyclotrons among users are the
major factors driving the growth of this market segment.
The
research applications segment is estimated to grow at the highest rate
during the forecast period
On the basis of
application, the particle therapy market has been segmented into
treatment and research applications. The research applications segment
is estimated to grow at the highest rate during the forecast period due
to factors such as the growing awareness about the research applications
of particle therapy systems, development of cost-effective and
technologically advanced diagnostic and therapeutic particle therapy
systems, and the increasing industry-academia collaborations in the
field of research.
North America to account for
the second-largest share of the global market in 2018
The
particle therapy market is segmented into four major regions, namely,
North America, Europe, the Asia Pacific, and the Rest of the World.
North America is expected to account for the second-largest share of the
global particle therapy market in 2018. Technological advancements in
the field of particle therapy, the rising incidence of cancer, easy
accessibility to treatments, and the high adoption of advanced
diagnostic technologies (owing to the significant per capita annual
healthcare expenditure by the US and Canadian governments) are some of
the key factors supporting the growth of the North American market.
Furthermore, favorable government initiatives that are creating awareness and promoting the adoption of proton therapy among key end users are some of the other major factors driving the growth of the particle therapy market in North America.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive
Summary
4 Premium Insights
5 Market Overview
6
Particle Therapy Market, By Type
7 Particle Therapy Market,
By Product & Service
8 Particle Therapy Market, By System
9
Particle Therapy Market, By Cancer Type
10 Particle Therapy
Market, By Application
11 Particle Therapy Market, By Region
12
Competitive Landscape
13 Company Profiles
- Advanced Oncotherapy PLC.
- Danfysik A/S
- Hitachi, Ltd.
- Ion Beam Applications Sa (IBA)
- Mevion Medical Systems, Inc.
- Optivus Proton Therapy, Inc.
- Protom International, Inc.
- Provision Healthcare, LLC
- Sumitomo Heavy Industries, Ltd.
- Varian Medical Systems, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/v2pgtj/particle_therapy?w=4